Harvard Bioscience, Inc. (NASDAQ:HBIO)

CAPS Rating: 4 out of 5

A developer, manufacturer and marketer of a range of specialized products, primarily apparatus and scientific instruments, used to improve life science research at pharmaceutical & biotechnology companies, universities & government laboratories worldwide.

Recs

1
Player Avatar TMFDeej (99.46) Submitted: 1/20/2013 9:54:24 PM : Outperform Start Price: $4.61 HBIO Score: +18.22

Harvard Bioscience is in the process of spinning off its money-losing HART division, leaving behind a manufacturer of scientific instruments trading for only three times earnings, yet growing at 15% to 20% per year.See Jim Royal's great article on the situation for more information:http://www.fool.com/investing/general/2013/01/18/im-putting-real-money-on-harvard-bioscience.aspxDeej

Featured Broker Partners


Advertisement